1
Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC
Condition(s):Locally Advanced Non-Small Cell Lung CancerLast Updated:December 22, 2021Recruiting
Atovaquone: 58 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
Atovaquone for Treatment of COVID-19
Condition(s):COVID-19Last Updated:December 14, 2021Completed
3
Atovaquone as Tumour HypOxia Modifier
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:September 4, 2019Completed
4
Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
Condition(s):Covid19Last Updated:March 4, 2022Terminated
5
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
Condition(s):Acute Myeloid LeukemiaLast Updated:February 23, 2022Active, not recruiting
6
Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension
Condition(s):MalariaLast Updated:March 22, 2017Completed
7
The ASAP Study – Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia
Condition(s):MalariaLast Updated:March 2, 2021Active, not recruiting
8
Weekly Dosing of Malarone ® for Prevention of Malaria
Condition(s):MalariaLast Updated:November 25, 2013Completed
9
Antiretroviral Drug Interaction Study in Volunteers With HIV
Condition(s):HIV; PCP; ToxoplasmosisLast Updated:July 5, 2018Completed
10
Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children
Condition(s):Pneumonia, Pneumocystis Carinii; HIV InfectionsLast Updated:October 28, 2021Completed